Form D — ReAlta Life Sciences, Inc.
0001752530-25-000002 · filed May 21, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $30,000,002
- Reported amount sold
- $29,929,943
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ReAlta Life Sciences, Inc.
- CIK
- 1752530
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5665 LOWERY ROAD, SUITE 100
NORFOLK, Virginia 23502 - Phone
- 757-901-0460
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Marek · Executive OfficerNorfolk, Virginia Find on LinkedIn ↗
-
Edward Heidt, Jr. · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Frank Gadams · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Laurie Glimcher · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Mert Aktar · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Andrew Miller · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Christi Shaw · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Emma Reeve · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Lewis Williams · DirectorNorfolk, Virginia Find on LinkedIn ↗
-
Paolo Martini · Executive OfficerNorfolk, Virginia Find on LinkedIn ↗
-
John Rickman · Executive OfficerNorfolk, Virginia Find on LinkedIn ↗
-
Neel Krishna · Executive OfficerNorfolk, Virginia Find on LinkedIn ↗
-
Kenji Cunnion · Executive OfficerNorfolk, Virginia Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗